Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Originally approved for treating type 2 diabetes in 2017 under the brand names Ozempic and Rybelsus (oral version), GLP-1 has gained attention for its weight loss effects
Scale bar, 50 m
A 2023 study also revealed that the use of GLP-1 agonists for weight loss is linked to an increased risk of developing the following conditions: The incidence of acute pancreatitis and pancreatic cancer was studied in 56,000 type 2 diabetes mellitus patients on GLP-1 medication for 1 to 5 years
They also produce moles, which are usually harmless but occasionally can become cancerous
US$ 25.18
US$ 23.73
US$ 27.52
